https://www.selleckchem.com/products/gdc-0068.html
It seems that emodin may have the potential to inhibit cancer cell growth and enhance cisplatin therapy in cancer with resistance. Collectively, our finding reveals a novel AURKA inhibitor, emodin, which may be vulnerable to ovarian cancer therapy in the future. To investigate the barriers and facilitators of foot care practice in diabetic patients in Indonesia. A qualitative content analysis with an inductive approach. Semi-structured interviews were conducted on 34 type 2 diabetes mellitus (T2DM) patients, health providers and family
Aimer
Commentaire
Partagez
